Carcinoma, Non-Small-Cell Lung
"Carcinoma, Non-Small-Cell Lung" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.
MeSH Number(s)
C04.588.894.797.520.109.220.249
C08.381.540.140.500
C08.785.520.100.220.500
Concept/Terms
Carcinoma, Non-Small-Cell Lung- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Non Small Cell Lung
- Carcinomas, Non-Small-Cell Lung
- Lung Carcinoma, Non-Small-Cell
- Lung Carcinomas, Non-Small-Cell
- Non-Small-Cell Lung Carcinomas
- Non-Small Cell Lung Cancer
- Non-Small-Cell Lung Carcinoma
- Non Small Cell Lung Carcinoma
- Carcinoma, Non-Small Cell Lung
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Non-Small-Cell Lung".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Non-Small-Cell Lung".
This graph shows the total number of publications written about "Carcinoma, Non-Small-Cell Lung" by people in Harvard Catalyst Profiles by year, and whether "Carcinoma, Non-Small-Cell Lung" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 7 | 2 | 9 |
| 1992 | 7 | 0 | 7 |
| 1993 | 10 | 0 | 10 |
| 1994 | 15 | 4 | 19 |
| 1995 | 20 | 5 | 25 |
| 1996 | 15 | 3 | 18 |
| 1997 | 9 | 5 | 14 |
| 1998 | 19 | 1 | 20 |
| 1999 | 14 | 2 | 16 |
| 2000 | 12 | 3 | 15 |
| 2001 | 26 | 5 | 31 |
| 2002 | 18 | 5 | 23 |
| 2003 | 26 | 5 | 31 |
| 2004 | 32 | 4 | 36 |
| 2005 | 64 | 6 | 70 |
| 2006 | 48 | 13 | 61 |
| 2007 | 53 | 9 | 62 |
| 2008 | 74 | 6 | 80 |
| 2009 | 70 | 8 | 78 |
| 2010 | 81 | 8 | 89 |
| 2011 | 89 | 9 | 98 |
| 2012 | 85 | 14 | 99 |
| 2013 | 97 | 11 | 108 |
| 2014 | 116 | 17 | 133 |
| 2015 | 152 | 13 | 165 |
| 2016 | 143 | 22 | 165 |
| 2017 | 117 | 12 | 129 |
| 2018 | 156 | 11 | 167 |
| 2019 | 147 | 7 | 154 |
| 2020 | 59 | 5 | 64 |
| 2021 | 3 | 0 | 3 |
Below are the most recent publications written about "Carcinoma, Non-Small-Cell Lung" by people in Profiles.
-
A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer. Ann Surg. 2021 03 01; 273(3):595-605.
-
Predictive biomarkers for response to immune checkpoint inhibitors in lung cancer: PD-L1 and beyond. Virchows Arch. 2021 Jan; 478(1):31-44.
-
Distribution of KRASG12C Somatic Mutations across Race, Sex, and Cancer Type. N Engl J Med. 2021 01 14; 384(2):185-187.
-
Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer. Ann Surg. 2020 12; 272(6):925-929.
-
Adjuvant therapy following induction therapy and surgery improves survival in N2-positive non-small cell lung cancer. J Surg Oncol. 2021 Feb; 123(2):579-586.
-
Outcomes of superior segmentectomy versus lower lobectomy for superior segment Stage I non-small-cell lung cancer are equivalent: An analysis of 196 patients at a single, high volume institution. J Surg Oncol. 2021 Feb; 123(2):570-578.
-
Commentary: Find, resect, and treat: The evolving early-stage small cell lung cancer story. J Thorac Cardiovasc Surg. 2021 03; 161(3):774-775.
-
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer. N Engl J Med. 2020 11 19; 383(21):2018-2029.
-
Finding the "True" N0 Cohort: Technical Aspects of Near-infrared Sentinel Lymph Node Mapping in Non-small Cell Lung Cancer. Ann Surg. 2020 10; 272(4):583-588.
-
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer. Ann Oncol. 2020 12; 31(12):1725-1733.